The Cardiorenal Forum (CRF) is an independent group formed in 2006. The key objective of the group is to highlight the important clinical overlap that exists between patients presenting with a primary cardiovascular or renal problem. Raising awareness of this and bringing together clinicians that are involved in the management of such patients will, we believe, translate into improved patient care. Whilst the Forum will primarily focus on delivery of high quality education and debate, we anticipate that it will provide the foundation for collaborative research between specialties.

Professional membership is open and free to all NHS and academic professionals involved in the care of patients with cardiovascular and kidney disease, including cardiologists/cardiovascular physicians, nephrologists, diabetologists, general practitioners and allied nursing and clinical scientists.

An Open Section membership is open to others including those in the pharmaceutical industry, medical device/diagnostics manufacturers etc.

We are able to offer attendance at a reduced charge thanks to generous and unrestricted support from the pharmaceutical industry.

Our first scientific meeting was held at the Zoological Society of London in 2006. We have held an annual meeting ever since. Reports from meetings are published in the British Journal of Cardiology, the official journal of the Forum.

Future aims of the Forum are to hold topic specific meetings throughout the year and to bring the Forum to a wider audience (The International Cardiorenal Forum). We will also be publishing newsletters and papers of scientific interest and we will hopefully increase our membership in the years to come.

The Cardiorenal Forum (CRF) was delighted to enter an academic partnership with the Kidney Disease Improving Global Outcomes (KDIGO) organisation in December 2020. The intention is to promote awareness, communications, and education in the rapidly developing field of cardiorenal medicine.

KDIGO is the global organisation developing and implementing evidence-based clinical practice guidelines in kidney disease. It is an independent, volunteer-led, self-managed charity incorporated in Belgium accountable to the public and the patients it serves. Visit www.kdigo.org.

On announcing the partnership, Cardiorenal Forum co-founder, Professor Philip Kalra (Consultant Nephrologist, Salford Royal NHS Foundation Trust; Professor of Renal Medicine, University of Manchester) commented: "We are very pleased to formalise links with KDIGO. Our mutual objectives are to highlight the importance of the clinical overlap between patients presenting with a primary cardiovascular or renal problem. Raising awareness of this and bringing together clinicians who are involved in the management of these patients will, we believe, translate into improved patient care."

John Davis, Chief Executive Officer, KDIGO commented: "We are pleased to collaborate with the Cardiorenal Forum. The Forum will assist us with the dissemination of KDIGO guidelines, notably our most recent publication of 'Diabetes management in chronic kidney disease' https://kdigo.org/guidelines/diabetes-ckd/."